Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001080
Filing Date
2025-01-08
Accepted
2025-01-08 14:07:35
Documents
1
Period of Report
2025-01-08

Document Format Files

Seq Description Document Type Size
1 form4-01082025_070130.html 4  
1 form4-01082025_070130.xml 4 12255
  Complete submission text file 0001415889-25-001080.txt   13765
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BLVD., SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address
Yarema Kristin (Reporting) CIK: 0001803794 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 25517874